반응형
Global Data Intelligence Center 
구분 보고서 (영문) 업로드
날짜
제약/바이오/
임상시험
Results from Phase III trial bring subcutaneous Ocrevus closer to its potential approval 07-19-2023
Pfizer, Gilead, and GSK Set to Capture 62% of $150 Billion Infectious Diseases Sales 07-18-2023
JNJ-2113’s Encouraging Results on Skin Clearance Demonstrates Potential for Psoriasis 07-24-2023
Clinical Trials: Precision and Personalized Medicine 07-26-2023
Revenue Surge Seen in 15 of the Top 20 Mega and Large Biopharma Companies in 2022 07-27-2023
Promising Results in Phase III Trial for First-Ever TROP2 Therapy for NSCLC 07-28-2023
ADC Therapeutics’s Zynlonta Fails Expectations in Phase II Trial for DLBCL Patients 07-28-2023
Bernie Sanders Plans More Drug Price Caps as Big Pharma Fights Back 07-28-2023
질환별 Preventative Measures Set to Battle for RSV Market Domination 07-19-2023
Risk of Alzheimer’s Disease Is Higher in the Older Black Population 07-21-2023
Updated US Pediatric Cancer Estimate Shows Increasing Lymphoid Leukemia Incidence 07-20-2023
Battling the Opioid Crisis: NHS’s Action Plan to Curb Addiction in the UK 07-24-2023
Post-Traumatic Stress Disorder (PTSD): Competitive Landscape 07-25-2023
Primary Immune Deficiency: Competitive Landscape 07-27-2023
Researchers Find Potential Association Between Cadmium and Endometriosis 07-27-2023
Bone Cancer Trials in 2023 07-28-2023
Dyslipidemia: Seven-Market Drug Forecast and Market Analysis 07-28-2023
AmerisourceBergen Is Supporting Integration of H2O Therapeutics’s Parky DTx App Within Healthcare Systems 07-31-2023
Spinal Muscular Atrophy: Competitive Landscape 07-31-2023
컨퍼런스/심포지엄/학회 Conference Organizing Tool – ESC 2023 07-27-2023

 

반응형

+ Recent posts